Report Buyer, the online destination for business intelligence for major industry sectors, is proud to announce the recent signature of a Sales and Marketing agreement with Insight Pharma Reports, a life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organisations.

Commenting on the agreement, Christina Belloge, Publisher Relations Manager at Report Buyer, said:

“I’m delighted that Insight Pharma Reports and Report Buyer will start a much anticipated relationship. This comes at a perfect timing in the current economic situation. I am convinced that the high level of expertise conveyed in their report range will match our customer’s expectations in terms of the latest developments in pharmaceutics.”

There are a number of Insight Pharma Reports reports available on Reportbuyer.com, these range from ‘Molecular Imaging in Drug R&D and Medical Practice’ to their most recent report ‘Approaches to Reducing Phase II Attrition’ which alyses results from a survey of current practices and views toward improving the efficiency and effectiveness of drug development.

About Insight Pharma Reports

Insight Pharma Reports cover key issues in drug discovery and development. Their reports are used by leading pharmaceutical, biotech, diagnostic, and other life science companies to keep abreast of the latest developments in pharmaceutical R&D (Research and Development) and their potential applications and business impacts. Written by experts in consulting and industry and supported by hundreds of hours of primary and secondary research.

View Insight Pharma Reports

About Report Buyer

Report Buyer is the independent online store for global business information. The website now lists more than 95,000 company overviews, market research reports, industry studies and business books from over 270 specialist publishers. Thousands of professionals from across the world make ReportBuyer.com their first choice in their search for quality business insight.